MedPath

Surgery Plus Medroxyprogesterone in Preventing Endometrial Cancer

Phase 2
Terminated
Conditions
Endometrial Cancer
Registration Number
NCT00003179
Lead Sponsor
Gynecologic Oncology Group
Brief Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of surgery with or without medroxyprogesterone may be an effective way to prevent the development of endometrial cancer in patients who have endometrial hyperplasia.

PURPOSE: Phase II trial to compare the effectiveness of surgery alone with that of medroxyprogesterone followed by surgery in preventing endometrial cancer in patients who have endometrial hyperplasia.

Detailed Description

OBJECTIVES:

* Determine the joint occurrence of atypical hyperplasia and adenocarcinoma in patients diagnosed at initial biopsy to have complex atypical hyperplasia.

* Compare the histologic response rates in patients with atypical endometrial hyperplasia treated with oral medroxyprogesterone acetate (Provera) vs intramuscular medroxyprogesterone acetate suspension (Depo-Provera) .

OUTLINE: This is a randomized, two-part study.

* Part A: Patients undergo immediate hysterectomy.

* Part B: Patients are randomized to 1 of 2 arms.

* Arm I: Patients receive oral medroxyprogesterone acetate (Provera) once daily for 3 months.

* Arm II: Patients receive medroxyprogesterone acetate suspension (Depo- Provera) intramuscularly once monthly for 3 months (days 1, 31, and 62).

Patients undergo hysterectomy at the end of the third month.

Patients are followed every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.

PROJECTED ACCRUAL: A minimum of 360 patients for part A and 140 patients (70 per arm) for part B will be accrued for this study.

Recruitment & Eligibility

Status
TERMINATED
Sex
Female
Target Recruitment
360
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (31)

State University of New York Health Sciences Center - Stony Brook

πŸ‡ΊπŸ‡Έ

Stony Brook, New York, United States

Duke Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Durham, North Carolina, United States

Arizona Cancer Center

πŸ‡ΊπŸ‡Έ

Tucson, Arizona, United States

Cooper Hospital/University Medical Center

πŸ‡ΊπŸ‡Έ

Camden, New Jersey, United States

Marlene and Stewart Greenebaum Cancer Center, University of Maryland

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Albert B. Chandler Medical Center, University of Kentucky

πŸ‡ΊπŸ‡Έ

Lexington, Kentucky, United States

Holden Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Iowa City, Iowa, United States

Keesler Medical Center - Keesler AFB

πŸ‡ΊπŸ‡Έ

Keesler AFB, Mississippi, United States

Cancer Center at the University of Virginia

πŸ‡ΊπŸ‡Έ

Charlottesville, Virginia, United States

Norwegian Radium Hospital

πŸ‡³πŸ‡΄

Oslo, Norway

Washington University School of Medicine

πŸ‡ΊπŸ‡Έ

Saint Louis, Missouri, United States

Abington Memorial Hospital

πŸ‡ΊπŸ‡Έ

Abington, Pennsylvania, United States

Comprehensive Cancer Center at Wake Forest University

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

Walter Reed Army Medical Center

πŸ‡ΊπŸ‡Έ

Washington, District of Columbia, United States

Community Hospital of Los Gatos

πŸ‡ΊπŸ‡Έ

Los Gatos, California, United States

Chao Family Comprehensive Cancer Center

πŸ‡ΊπŸ‡Έ

Orange, California, United States

University of Chicago Cancer Research Center

πŸ‡ΊπŸ‡Έ

Chicago, Illinois, United States

Indiana University Cancer Center

πŸ‡ΊπŸ‡Έ

Indianapolis, Indiana, United States

University of Mississippi Medical Center

πŸ‡ΊπŸ‡Έ

Jackson, Mississippi, United States

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support

πŸ‡ΊπŸ‡Έ

Bethesda, Maryland, United States

Ellis Fischel Cancer Center - Columbia

πŸ‡ΊπŸ‡Έ

Columbia, Missouri, United States

Barrett Cancer Center

πŸ‡ΊπŸ‡Έ

Cincinnati, Ohio, United States

Cleveland Clinic Taussig Cancer Center

πŸ‡ΊπŸ‡Έ

Cleveland, Ohio, United States

Milton S. Hershey Medical Center

πŸ‡ΊπŸ‡Έ

Hershey, Pennsylvania, United States

Medical University of South Carolina

πŸ‡ΊπŸ‡Έ

Charleston, South Carolina, United States

University of Texas Medical Branch

πŸ‡ΊπŸ‡Έ

Galveston, Texas, United States

Brookview Research, Inc.

πŸ‡ΊπŸ‡Έ

Nashville, Tennessee, United States

Fletcher Allen Health Care - Medical Center Campus

πŸ‡ΊπŸ‡Έ

Burlington, Vermont, United States

Arthur G. James Cancer Hospital - Ohio State University

πŸ‡ΊπŸ‡Έ

Columbus, Ohio, United States

University of Oklahoma College of Medicine

πŸ‡ΊπŸ‡Έ

Oklahoma City, Oklahoma, United States

Β© Copyright 2025. All Rights Reserved by MedPath